Literature DB >> 17440138

Diabetes drugs tied to fractures in women.

Tracy Hampton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17440138     DOI： 10.1001/jama.297.15.1645

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Naga Chalasani; Kris V Kowdley; Arthur McCullough; Anna Mae Diehl; Nathan M Bass; Brent A Neuschwander-Tetri; Joel E Lavine; James Tonascia; Aynur Unalp; Mark Van Natta; Jeanne Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  N Engl J Med       Date:  2010-04-28       Impact factor: 91.245

Review 2.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

3.  The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study.

Authors:  F-Y Hsiao; C D Mullins
Journal:  Diabetologia       Date:  2009-11-27       Impact factor: 10.122

4.  MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema.

Authors:  Francine M Gregoire; Fang Zhang; Holly J Clarke; Thomas A Gustafson; Dorothy D Sears; Svetlana Favelyukis; James Lenhard; Dennis Rentzeperis; L Edward Clemens; Yi Mu; Brian E Lavan
Journal:  Mol Endocrinol       Date:  2009-04-23

Review 5.  Risk of fractures with glitazones: a critical review of the evidence to date.

Authors:  Michael Bodmer; Christian Meier; Marius E Kraenzlin; Christoph R Meier
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 6.  Interpreting adverse signals in diabetes drug development programs.

Authors:  Clifford J Bailey
Journal:  Diabetes Care       Date:  2013-05-21       Impact factor: 19.112

7.  Should We Use PPAR Agonists to Reduce Cardiovascular Risk?

Authors:  Jennifer G Robinson
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

8.  Interprofessional faculty development: integration of oral health into the geriatric diabetes curriculum, from theory to practice.

Authors:  Georgia Dounis; Marcia Ditmyer; Susan Vanbeuge; Sue Schuerman; Mildred McClain; Kiki Dounis; Connie Mobley
Journal:  J Multidiscip Healthc       Date:  2013-12-09

9.  Delayed fracture healing and increased callus adiposity in a C57BL/6J murine model of obesity-associated type 2 diabetes mellitus.

Authors:  Matthew L Brown; Kiminori Yukata; Christopher W Farnsworth; Ding-Geng Chen; Hani Awad; Matthew J Hilton; Regis J O'Keefe; Lianping Xing; Robert A Mooney; Michael J Zuscik
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

Review 10.  Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis.

Authors:  Huang-Jun Liu; Hai-Han Liao; Zheng Yang; Qi-Zhu Tang
Journal:  PPAR Res       Date:  2016-05-12       Impact factor: 4.964
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.